ArticleOncotarget2016

The novel choline kinase inhibitor ICL-CCIC-0019 reprograms cellular metabolism and inhibits cancer cell growth.

Sebastian Trousil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.